ASTRO: Shorter irradiation effective for breast cancer treatment
A three-week radiation therapy course is as safe and effective as conventiona...Read more on AuntMinnie.comRelated Reading:
ASTRO: Radiation therapy boosts survival rate from liver cancer
ASTRO: Shortened radiotherapy is effective in high-risk prostate cancer
ASTRO: Physicists add value in patient-facing role
ASTRO: Radiation to prevent pain may also prolong life (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 25, 2022 Category: Radiology Source Type: news
ASTRO: AI model predicts hospitalizations in outpatient cancer patients
An artificial intelligence (AI) model trained on fitness tracker data can predic...Read more on AuntMinnie.comRelated Reading:
ASTRO: Radiation therapy boosts survival rate from liver cancer
ASTRO: Shortened radiotherapy is effective in high-risk prostate cancer
How higher radiation stacks up when treating lung cancer
PET/MRI, CT predict pancreatic cancer treatment response
CT radiomics predicts esophageal cancer outcomes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 25, 2022 Category: Radiology Source Type: news
Shorter Course of Radiation Therapy Proves Mettle in High-Risk Prostate Cancer
(MedPage Today) -- SAN ANTONIO -- A shortened radiation therapy (RT) protocol for high-risk prostate cancer led to similar outcomes with no increase in toxicity compared with the standard treatment schedule, a randomized trial showed.
Overall... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 25, 2022 Category: Hematology Source Type: news
ASTRO: Therapy combo may slow growth of prostate cancer
Prostate cancer patients who receive radiation in addition to intermittent hormon...Read more on AuntMinnie.comRelated Reading:
ASTRO: Radiation therapy boosts survival rate from liver cancer
ASTRO: Shortened radiotherapy is effective in high-risk prostate cancer
ASTRO: Radiation to prevent pain may also prolong life
Ga-68 PSMA-11 improves outcomes in prostate cancer patients
SABR slows prostate cancer progression (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 25, 2022 Category: Radiology Source Type: news
Mayo Clinic Q & amp;A podcast: Proton beam therapy offers benefits to patients with breast cancer
The type of breast cancer a person has and how far it has spread determine the appropriate treatment. Previously, a patient with breast cancer might have received five to six weeks of radiation therapy. But the approach is changing. "For many years, we had the understanding that giving a little bit of radiation each day and spreading that treatment out over multiple weeks was the gentlest on the normal tissues, and that would lead to… (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - October 25, 2022 Category: Hospital Management Source Type: news
IBA expands use of myQA iON software to radiation therapy
At the American Society for Radiation Oncology annual meeting in San Antonio...Read more on AuntMinnie.comRelated Reading:
IBA software now compatible with Varian software
IBA and SCK CEN pick name for autonomous joint venture
NorthStar buys two additional accelerators from IBA
IBA reports revenue increase in first half of 2022
IBA to collaborate with ScandiDos (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 24, 2022 Category: Radiology Source Type: news
AI model predicts hospitalizations in outpatient cancer patients
An artificial intelligence (AI) model trained on fitness tracker data can predic...Read more on AuntMinnie.comRelated Reading:
ASTRO: Radiation therapy boosts survival rate from liver cancer
ASTRO: Shortened radiotherapy is effective in high-risk prostate cancer
How higher radiation stacks up when treating lung cancer
PET/MRI, CT predict pancreatic cancer treatment response
CT radiomics predicts esophageal cancer outcomes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 24, 2022 Category: Radiology Source Type: news
ViewRay highlights clinical results at ASTRO
ViewRay is highlighting clinical results from a phase II trial that explore...Read more on AuntMinnie.comRelated Reading:
SUNY Upstate installs ViewRay radiation therapy system
ViewRay signs MD Anderson Cancer Center
ViewRay's radiation therapy system can be sold in China
ViewRay signs VA Houston Healthcare System
ViewRay reports revenue spike for Q2 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 24, 2022 Category: Radiology Source Type: news
Rapid Radiotherapy Technique Shows Promise in First Human Trial
(MedPage Today) -- SAN ANTONIO -- A radiation treatment that delivers therapeutic doses in a fraction of a second appeared to be a promising option in mitigating the side effects associated with conventional radiation therapy, according to results... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - October 24, 2022 Category: Radiology Source Type: news
ASTRO: Radiation therapy boosts survival rate from liver cancer
Combining radiation therapy and chemotherapy to treat patients with advance...Read more on AuntMinnie.comRelated Reading:
ASTRO issues guide on radiation therapy for glioma
ASTRO sees opportunity in CMS delay of RO Model
ASTRO releases EBRT guidelines for liver cancer treatment
CMS changes to RO Model draw ASTRO's ire
Study evaluates safety of new liver cancer treatment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 24, 2022 Category: Radiology Source Type: news
New Standard-of-Care Therapy for Advanced Liver Cancer
(MedPage Today) -- SAN ANTONIO -- Adding radiation therapy to systemic treatment significantly improved overall survival (OS) in advanced liver cancer, according to a randomized trial reported here.
Median OS improved from 12.3 months with the... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 24, 2022 Category: Gastroenterology Source Type: news
ViewRay Announces Primary Endpoint Outcome from First Prospective, Multi-Institutional Study to Deliver Ablative Doses of Radiation to Pancreatic Cancer Patients
Study's primary objective of low grade 3+ toxicity was met; exploration of secondary outcomes underway to confirm local control rates and patient outcomes with MRIdian SMART
DENVER, Oct. 24, 2022 -- (Healthcare Sales & Marketing Network) -- ViewRay, In... Devices, Oncology ViewRay, MRIdian, MRI-guided radiation therapy, MRIdian A3i (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 24, 2022 Category: Pharmaceuticals Source Type: news
ASTRO: Physicists add value in patient-facing role
Radiation therapy patients report less anxiety when a medical physicist explain...Read more on AuntMinnie.comRelated Reading:
Don't modify the quench button: MRI safety grabs attention at ISMRM
Patients lack knowledge on radiation in medical imaging
Assigning dedicated MRI safety roles can reduce risk
No shield from x-rays: How science is rethinking lead aprons
Can radiation therapy and cremation safely coexist? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 24, 2022 Category: Radiology Source Type: news
Local Therapy Extends Use of Targeted Drugs in Oligoprogressive Lung Cancer
(MedPage Today) -- Patients with advanced, mutated lung cancer had "clinically meaningful" continuation of treatment beyond progression following local therapy, primarily radiation therapy (RT), a small retrospective analysis showed.
The median... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 21, 2022 Category: Hematology Source Type: news
UCLA researchers identify gene as potential target in treatment-resistant brain cancer
Doctors and scientists at UCLA Jonsson Comprehensive Cancer Center and the UCLA Jane and Terry Semel Institute for Neuroscience and Human Behavior have identified a gene that may provide a therapeutic target for the deadly, treatment-resistant brain cancer glioblastoma multiforme.The gene, P300, enables cancer cells that have been damaged by radiation therapy to recover by rearranging DNA and initiating a molecular mechanism that refortifies tumor cells for growth and survival.In studies using mice and in human glioblastoma multiforme cells, the scientists discovered that blocking P300 disrupted its ability to set ...
Source: UCLA Newsroom: Health Sciences - October 20, 2022 Category: Universities & Medical Training Source Type: news
